Sec. 7304. GAO report on structural and systemic factors that perpetuate cardiovascular disparities
301 words·~1 min read·
/bill/118/s/4773/is/section-7304·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than September 30, 2025, the Government Accountability Office shall prepare and submit a report to Congress that contains the results of an investigation of— the structural and systemic factors that perpetuate disparities in access to screenings, care, and treatment of cardiovascular disease; and how care navigation, including community-based health workers, can improve cardiovascular disease management and improve health outcomes. The report shall— identify the challenges and barriers facing healthcare providers and patients, which contribute to postponed, delayed, or suboptimal treatments for cardiovascular disease; examine efforts by Federal agencies and Federal programs to improve screening and management of patients with cardiovascular disease; identify and examine existing quality measures from the Centers for Medicare & Medicaid Services related to cholesterol management and whether these measures encourage providers and health systems to— perform appropriate and timely low-density-lipoprotein cholesterol (LDL-C) testing on patients at risk of a cardiovascular event; and better manage patients’ elevated LDL-C levels in concordance with clinical guidelines prescribing directives to ensure patients are progressing towards guideline-recommended LDL-C levels; identify actions the Federal government could take to promote collaboration with community-based organizations to ensure improvement in clinical outcomes for patients with cardiovascular disease, including by building on recommendations from the Institutes of Medicine and the Centers for Disease Control to include community health workers to improve health care delivery for underserved and high-risk communities; and assess whether racial and ethnic minority groups, as defined in section 1707(g) of the Public Health Service Act ( 42 U.S.C. 300g–6(g) ), have higher prior authorization rejection rates of prescription drugs to treat or prevent cardiovascular disease by health insurance providers and, if so, identify the resulting impacts on cardiovascular disease medication adherence, morbidity, and mortality, as well as resulting postponed, delayed, or suboptimal treatment prescribing for cardiovascular disease among racial and ethnic minorities.
Connections1 off-index
1 reference not yet in our index
- 42 USC 300g–6(g)
Citation graph
cites case law
Sec. 7304
GAO report on structural and systemic factors that perpetuate cardiovascular disparities
Cite42 USC 300g–6(g)
Cites 1Cited by 0 across 0 sources